Primary Record
Murepavadin
Note: Only for scientific research or as raw materials for production.
- In stock
- 9,600 g
- Purity
- 99.5 %
- CAS
- 944252-63-5
Compound Identifiers & Properties
- CAS
- 944252-63-5
- PubChem CID
- 91824766
- SMILES
- CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2CCC[C@@H]2C(=O)N3CCC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC4=CNC5=CC=CC=C54)[C@@H](C)O)CO)C)CCN)CCN)CC6=CNC7=CC=CC=C76)CCN)CCN)CCCN)CCN
- Canonical SMILES
- CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCN)NC(=O)[C@@H](CCN)NC(=O)[C@H](CCCN)NC(=O)[C@H](CCN)NC1=O
Names & Synonyms
- Murepavadin
- Murepavadina
- Murepavadine
- Murepavadin [INN]
- murepavadinum
- MUREPAVADIN TFA
- Murepavadin TFA salt
- POL7080
- 944252-63-5
- UNII-0D02GRY87Z
- 0D02GRY87Z
- Murepavadin [USAN:INN]
- RefChem:819617
- Murepavadin (USAN/INN)
- MUREPAVADIN [USAN]
- Murepavadin (POL7080)
- RO7033877
- MUREPAVADIN [WHO-DD]
- POL7080 (TFA)
- POL-7080
- POL7080 TFA
- CHEMBL3946483
- SCHEMBL29458093
- GTPL10832
- GLXC-21558
- RO-7033877
- EX-A4063
- UMB25263
- RG7929
- AKOS037648482
- C73H112N22O16
- BAT-009093
- BAT-009288
- DB14777
- RG-7929
- BS-14122
- DA-65706
- J3.751.933B
- D10957
- D80443
- A943125
- 3H-1,2,4-Triazole-3-thione,2-amino-1,2-dihydro
- Cyclo(L-alanyl-L-seryl-D-prolyl-L-prolyl-L-threonyl-L-tryptophyl-L-isoleucyl-(2S)-2,4-diaminobutanoyl-L-ornithyl-(2R)-2,4-diaminobutanoyl-(2S)-2,4-diaminobutanoyl-L-tryptophyl-(2S)-2,4-diaminobutanoyl-(2S)-2,4-diaminobutanoyl)
- Q27236621
- (3R,9S,12S,15S,18S,21S,24S,27R,30S,33S,36S,39S,42S,45S)-15,18,24,27,33-pentakis(2-aminoethyl)-30-(3-aminopropyl)-36-[(2S)-butan-2-yl]-42-[(1R)-1-hydroxyethyl]-9-(hydroxymethyl)-21,39-bis(1H-indol-3-ylmethyl)-12-methyl-1,7,10,13,16,19,22,25,28,31,34,37,40,43-tetradecazatricyclo[43.3.0.03,7]octatetracontane-2,8,11,14,17,20,23,26,29,32,35,38,41,44-tetradecone
- (3R,9S,12S,15S,18S,21S,24S,27R,30S,33S,36S,39S,42S,45S)-15,18,24,27,33-pentakis(2-aminoethyl)-30-(3-aminopropyl)-36-((2S)-butan-2-yl)-42-((1R)-1-hydroxyethyl)-9-(hydroxymethyl)-21,39-bis(1H-indol-3-ylmethyl)-12-methyl-1,7,10,13,16,19,22,25,28,31,34,37,40,43-tetradecazatricyclo(43.3.0.03,7)octatetracontane-2,8,11,14,17,20,23,26,29,32,35,38,41,44-tetradecone
- (3R,9S,12S,15S,18S,21S,24S,27R,30S,33S,36S,39S,42S,45S)-15,18,24,27,33-pentakis(2-aminoethyl)-30-(3-aminopropyl)-36-[(2S)-butan-2-yl]-42-[(1R)-1-hydroxyethyl]-9-(hydroxymethyl)-21,39-bis[(1H-indol-3-yl)methyl]-12-methyl-1,7,10,13,16,19,22,25,28,31,34,37,40,43-tetradecaazatricyclo[43.3.0.03,7]octatetracontane-2,8,11,14,17,20,23,26,29,32,35,38,41,44-tetradecone
- (3R,9S,12S,15S,18S,21S,24S,27R,30S,33S,36S,39S,42S,45S)-15,18,24,27,33-pentakis(2-aminoethyl)-30-(3-aminopropyl)-42-[(1R)-1-hydroxyethyl]-9-(hydroxymethyl)-21,39-bis(1H-indol-3-ylmethyl)-12-methyl-36-[(1S)-1-methylpropyl]-1,7,10,13,16,19,22,25,28,31,34,37,40,43-tetradecazatricyclo[43.3.0.03,7]octatetracontane-2,8,11,14,17,20,23,26,29,32,35,38,41,44-tetradecone
- (6S,9S,12S,15S,18S,21S,24R,27S,30S,33S,36S,39S,41aS,46aR)-18,36-Bis((1H-indol-3-yl)methyl)-12,15,21,24,30-pentakis(2-aminoethyl)-27-(3-aminopropyl)-33-((S)-sec-butyl)-39-((R)-1-hydroxyethyl)-6-(hydroxymethyl)-9-methyltriacontahydro-1H,5H-dipyrrolo[1,2-a:1',2'-d][1,4,7,10,13,16,19,22,25,28,31,34,37,40]tetradecaazacyclodotetracontine-5,8,11,14,17,20,23,26,29,32,35,38,41,46(46aH)-tetradecaone
- cyclo(-L-threonyl-L-tryptophanyl-L-isoleucyl-L-2,4-diaminobutyryl-L-ornithyl-D-2,4-diaminobutyryl-L-2,4-diaminobutyryl-L-tryptophanyl-L-2,4-diaminobutyryl-L-2,4-diaminobutyryl-L-alanyl-L-seryl-D-prolyl-L-prolyl), acetate salt